✦ LIBER ✦

PND11 Budget Impact Analysis of First-Line Treatment for Relapsing – Remitting Multiple Sclerosis in Spain

✍ Scribed by R. Sánchez-de la Rosa; E. Sabater; M.A. Casado

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND8 COST-EFFECTIVENESS AND BUDGET IMPAC

✍ O Espallardo; C Crespo; C Polanco; D Nieves 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

PND8 COST-EFFECTIVENESS ANALYSIS OF REBI

✍ MJ Nuijten; T Mittendorf; A Jäcker; U Osowski 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PND28 Cost-Effectiveness Analysis of Int

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND5 Budget Impact Analysis of Fingolimo

✍ D. Rosselli; J.G. Ariza Lozano; T. Acosta; J.D. Rueda 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND23 Economic Evaluation of Natalizumab

✍ S.T. Alexopoulos; B. Deniz; A.R. Walker; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PND4 BUDGET IMPACT ANALYSIS OF NATALIZUM

✍ AL Ferreira Da Silva; A Finkelsztejn; R Ribeiro; CA Polanczyk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB